Diabetes and the enteric nervous system

Neurogastroenterology and Motility

Volumn 19, Issue 12, 2007, Pages 951-960

  Chandrasekharan, B ^a   Srinivasan, S ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

Diabetes; Enteric nervous system; Gastric emptying; Motility; Neuronal nitric oxide synthase; Neuropeptides

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANTIOXIDANT; CALCITONIN GENE RELATED PEPTIDE; CHOLINE ACETYLTRANSFERASE; GALANIN; GLUTATHIONE; NERVE GROWTH FACTOR; NEURONAL NITRIC OXIDE SYNTHASE; NEUROPEPTIDE; NEUROPEPTIDE Y; NEUROTROPHIN 3; REACTIVE OXYGEN METABOLITE; SEROTONIN; SOMATOMEDIN C; SUBSTANCE P; THIOCTIC ACID;

ABDOMINAL PAIN; APOPTOSIS; BLOATING; CONSTIPATION; DIABETES MELLITUS; DIABETIC NEUROPATHY; DIARRHEA; GASTROINTESTINAL MOTILITY; HUMAN; HYPERGLYCEMIA; INFLAMMATION; INTESTINE INNERVATION; INTESTINE MUSCLE; NAUSEA; NERVE CELL; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SPINAL GANGLION; STOMACH EMPTYING;

DIABETES MELLITUS; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; NERVE DEGENERATION;

EID: 36649004109     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2007.01023.x     Document Type: Review

References (76)

1. Bytzer P, Talley NJ, Leemon M et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001 161 : 1989 96.
2. Furness JB, Kunze WA, Clerc N. Nutrient tasting and signaling mechanisms in the gut II. The intestine as a sensory organ: neural, endocrine, and immune responses. Am J Physiol 1999 277 : G922 8.
3. Monckton G, Pehowich E. Autonomic neuropathy in the streptozotocin diabetic rat. Can J Neurol Sci 1980 7 : 135 42.
4. Fregonesi CE, de Miranda-Neto MH, Molinari SL et al. Quantitative study of the myenteric plexus of the stomach of rats with streptozotocin-induced diabetes. Arq Neuropsiquiatr 2001 59 : 50 3.
5. Zanoni JN, de Miranda Neto MH, Bazotte RB et al. Morphological and quantitative analysis of the neurons of the myenteric plexus of the cecum of streptozotocin-induced diabetic rats. Arq Neuropsiquiatr 1997 55 : 696 702.
6. Alves AM, Alves EP, Fregonesi CE et al. Morphoquantitative aspects of NADH-diaphorase myenteric neurons in the ileum of diabetic rats treated with acetyl-l-carnitine. Anat Histol Embryol 2006 35 : 13 8.
7. Furlan MM, Molinari SL, Miranda Neto MH. Morphoquantitative effects of acute diabetes on the myenteric neurons of the proximal colon of adult rats. Arq Neuropsiquiatr 2002 60 : 576 81.
8. Kishi M, Tanabe J, Schmelzer JD et al. Morphometry of dorsal root ganglion in chronic experimental diabetic neuropathy. Diabetes 2002 51 : 819 24.
9. Zanoni JN, Buttow NC, Bazotte RB et al. Evaluation of the population of NADPH-diaphorase-stained and myosin-V myenteric neurons in the ileum of chronically streptozotocin-diabetic rats treated with ascorbic acid. Auton Neurosci 2003 104 : 32 8.
10. De Miranda Neto MH, Defani MA, Fregonesi CE et al. Morphometric and quantitative evaluation of the NADH-diaphorase positive myenteric neurons of the jejunum of streptozotocin-diabetic rats supplemented with acetyl-L-carnitine. Anat Histol Embryol 2005 34 : 154 8.
11. Bult H, Boeckxstaens GE, Pelckmans PA et al. Nitric oxide as an inhibitory non-adrenergic non-cholinergic neurotransmitter. Nature 1990 345 : 346 7.
12. Takahashi T. Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. J Gastroenterol 2003 38 : 421 30.
13. Watkins CC, Sawa A, Jaffrey S et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000 106 : 373 84.
14. Wrzos HF, Cruz A, Polavarapu R et al. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci 1997 42 : 2106 10.
15. Takahashi T, Nakamura K, Itoh H et al. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997 113 : 1535 44.
16. Anitha M, Gondha C, Sutliff R et al. GDNF rescues hyperglycemia-induced diabetic enteric neuropathy through activation of the PI3K/Akt pathway. J Clin Invest 2006 116 : 344 56.
17. Cellek S, Foxwell NA, Moncada S. Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 2003 52 : 2353 62.
18. He CL, Soffer EE, Ferris CD et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001 121 : 427 34.
19. Iwasaki H, Kajimura M, Osawa S et al. A deficiency of gastric interstitial cells of Cajal accompanied by decreased expression of neuronal nitric oxide synthase and substance P in patients with type 2 diabetes mellitus. J Gastroenterol 2006 41 : 1076 87.
20. Adeghate E, al-Ramadi B, Saleh AM et al. Increase in neuronal nitric oxide synthase content of the gastroduodenal tract of diabetic rats. Cell Mol Life Sci 2003 60 : 1172 9.
21. Furlan MM, de Miranda-Neto MH, Sant'ana Dde M et al. Number and size of myenteric neurons of the duodenum of adult rats with acute diabetes. Arq Neuropsiquiatr 1999 57 : 740 5.
22. Shotton HR, Lincoln J. Diabetes only affects nitric oxide synthase-containing myenteric neurons that do not contain heme oxygenase 2. Brain Res 2006 1068 : 248 56.
23. El-Salhy M. Neuroendocrine peptides of the gastrointestinal tract of an animal model of human type 2 diabetes mellitus. Acta Diabetol 1998 35 : 194 8.
24. Nowak TV, Chey WW, Chang TM et al. Effect of streptozotocin-induced diabetes mellitus on release of vasoactive intestinal polypeptide from rodent small intestine. Dig Dis Sci 1995 40 : 828 36.
25. Eaker EY, Sallustio JE, Marchand SD et al. Differential increase in neuropeptide Y-like levels and myenteric neuronal staining in diabetic rat intestine. Regul Pept 1996 61 : 77 84.
26. Cox HM. Neuropeptide Y receptors; antisecretory control of intestinal epithelial function. Auton Neurosci 2007 133 : 76 85.
27. Feher E, Batbayar B, Ver A et al. Changes of the different neuropeptide-containing nerve fibers and immunocells in the diabetic rat's alimentary tract. Ann N Y Acad Sci 2006 1084 : 280 95.
28. Spangeus A, El-Salhy M. Myenteric plexus of obese diabetic mice (an animal model of human type 2 diabetes). Histol Histopathol 2001 16 : 159 65.
29. El-Salhy M. Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. J Diabetes Complicat 2001 15 : 277 84.
30. Belai A, Calcutt NA, Carrington AL et al. Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition. J Auton Nerv Syst 1996 58 : 163 9.
31. Spangeus A, Suhr O, El-Salhy M. Diabetic state affects the innervation of gut in an animal model of human type 1 diabetes. Histol Histopathol 2000 15 : 739 44.
32. LePard KJ. Choline acetyltransferase and inducible nitric oxide synthase are increased in myenteric plexus of diabetic guinea pig. Auton Neurosci 2005 118 : 12 24.
33. Belai A, Lincoln J, Milner P et al. Progressive changes in adrenergic, serotonergic, and peptidergic nerves in proximal colon of streptozotocin- diabetic rats. Gastroenterology 1988 95 : 1234 41.
34. Takahara H, Fujimura M, Taniguchi S et al. Changes in serotonin levels and 5-HT receptor activity in duodenum of streptozotocin-diabetic rats. Am J Physiol Gastrointest Liver Physiol 2001 281 : G798 808.
35. Lincoln J, Bokor JT, Crowe R et al. Myenteric plexus in streptozotocin-treated rats. Neurochemical and histochemical evidence for diabetic neuropathy in the gut. Gastroenterology 1984 86 : 654 61.
36. Gibbins IL, Furness JB, Costa M et al. Co-localization of calcitonin gene-related peptide-like immunoreactivity with substance P in cutaneous, vascular and visceral sensory neurons of guinea pigs. Neurosci Lett 1985 57 : 125 30.
37. Lysy J, Karmeli F, Sestieri M et al. Decreased substance P content in the rectal mucosa of diabetics with diarrhea and constipation. Metabolism 1997 46 : 730 4.
38. Ballmann M, Conlon JM. Changes in the somatostatin, substance P and vasoactive intestinal polypeptide content of the gastrointestinal tract following streptozotocin-induced diabetes in the rat. Diabetologia 1985 28 : 355 8.
39. Razavi R, Chan Y, Afifiyan FN et al. TRPV1+ sensory neurons control beta cell stress and islet inflammation in autoimmune diabetes. Cell 2006 127 : 1123 35.
40. Samsom M, Vermeijden JR, Smout AJ et al. Prevalence of delayed gastric emptying in diabetic patients and relationship to dyspeptic symptoms: a prospective study in unselected diabetic patients. Diabetes Care 2003 26 : 3116 22.
41. Jenkinson KM, Reid JJ. Altered non-adrenergic non-cholinergic neurotransmission in gastric fundus from streptozotocin-diabetic rats. Eur J Pharmacol 2000 401 : 251 8.
42. Srinivasan S, Stevens M, Wiley JW. Diabetic peripheral neuropathy: evidence for apoptosis and associated mitochondrial dysfunction. Diabetes 2000 49 : 1932 8.
43. Guo C, Quobatari A, Shangguan Y et al. Diabetic autonomic neuropathy: evidence for apoptosis in situ in the rat. Neurogastroenterol Motil 2004 16 : 335 45.
44. Surendran S, Kondapaka SB. Altered expression of neuronal nitric oxide synthase in the duodenum longitudinal muscle-myenteric plexus of obesity induced diabetes mouse: implications on enteric neurodegeneration. Biochem Biophys Res Commun 2005 338 : 919 22.
45. Jackson MW, Gordon TP, Waterman SA. Disruption of intestinal motility by a calcium channel-stimulating autoantibody in type 1 diabetes. Gastroenterology 2004 126 : 819 28.
46. Srinivasan S, Stevens MJ, Sheng H et al. Serum from patients with type 2 diabetes with neuropathy induces complement-independent, calcium-dependent apoptosis in cultured neuronal cells. J Clin Invest 1998 102 : 1454 62.
47. Giron MD, Salto R, Gonzalez Y et al. Modulation of hepatic and intestinal glutathione S-transferases and other antioxidant enzymes by dietary lipids in streptozotocin diabetic rats. Chemosphere 1999 38 : 3003 13.
48. Bhor VM, Raghuram N, Sivakami S. Oxidative damage and altered antioxidant enzyme activities in the small intestine of streptozotocin-induced diabetic rats. Int J Biochem Cell Biol 2004 36 : 89 97.
49. Semra YK, Wang M, Peat NJ et al. Selective susceptibility of different populations of sympathetic neurons to diabetic neuropathy in vivo is reflected by increased vulnerability to oxidative stress in vitro. Neurosci Lett 2006 407 : 199 204.
50. Carroll SL, Byer SJ, Dorsey DA et al. Ganglion-specific patterns of diabetes-modulated gene expression are established in prevertebral and paravertebral sympathetic ganglia prior to the development of neuroaxonal dystrophy. J Neuropathol Exp Neurol 2004 63 : 1144 54.
51. Vincent AM, Perrone L, Sullivan KA et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 2007 148 : 548 58.
52. Korenaga K, Micci MA, Taglialatela G et al. Suppression of nNOS expression in rat enteric neurones by the receptor for advanced glycation end-products. Neurogastroenterol Motil 2006 18 : 392 400.
53. Scott JN, Clark AW, Zochodne DW. Neurofilament and tubulin gene expression in progressive experimental diabetes: failure of synthesis and export by sensory neurons. Brain 1999 122 (Pt 11 2109 18.
54. Schmidt RE, Dorsey DA, Beaudet LN et al. Effect of IGF-I and neurotrophin-3 on gracile neuroaxonal dystrophy in diabetic and aging rats. Brain Res 2000 876 : 88 94.
55. Calcutt NA, Allendoerfer KL, Mizisin AP et al. Therapeutic efficacy of sonic hedgehog protein in experimental diabetic neuropathy. J Clin Invest 2003 111 : 507 14.
56. Shotton HR, Broadbent S, Lincoln J. Prevention and partial reversal of diabetes-induced changes in enteric nerves of the rat ileum by combined treatment with alpha-lipoic acid and evening primrose oil. Auton Neurosci 2004 111 : 57 65.
57. Nowak TV, Harrington B, Weisbruch JP et al. Structural and functional characteristics of muscle from diabetic rodent small intestine. Am J Physiol 1990 258 (5 Pt 1 G690 8.
58. Carrier GO, Aronstam RS. Increased muscarinic responsiveness and decreased muscarinic receptor content in ileal smooth muscle in diabetes. J Pharmacol Exp Ther 1990 254 : 445 9.
59. Soulie ML, Cros G, Serrano JJ et al. Impairment of contractile response to carbachol and muscarinic receptor coupling in gastric antral smooth muscle cells isolated from diabetic streptozotocin-treated rats and db/db mice. Mol Cell Biochem 1992 109 : 185 8.
60. Takahashi T, Kojima Y, Tsunoda Y et al. Impaired intracellular signal transduction in gastric smooth muscle of diabetic BB/W rats. Am J Physiol 1996 270 (3 Pt 1 G411 7.
61. Coulson FR, Jacoby DB, Fryer AD. Insulin regulates neuronal M2 muscarinic receptor function in the ileum of diabetic rats. J Pharmacol Exp Ther 2004 308 : 760 6.
62. Horvath VJ, Vittal H, Lorincz A et al. Reduced stem cell factor links smooth myopathy and loss of interstitial cells of cajal in murine diabetic gastroparesis. Gastroenterology 2006 130 : 759 70.
63. Gaddipati KV, Simonian HP, Kresge KM et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci 2006 51 : 1339 46.
64. Takehara K, Tashima K, Kato S et al. Failure of the nitric oxide synthase inhibitor to stimulate duodenal bicarbonate secretion in streptozotocin- diabetic rats. Life Sci 1997 60 : 1505 14.
65. Tougas G, Hunt RH, Fitzpatrick D et al. Evidence of impaired afferent vagal function in patients with diabetes gastroparesis. Pacing Clin Electrophysiol 1992 15 (10 Pt 2 1597 602.
66. Aitchison M, Fisher BM, Carter K et al. Impaired anal sensation and early diabetic faecal incontinence. Diabet Med 1991 8 : 960 3.
67. Yagihashi S, Sima AA. Diabetic autonomic neuropathy in BB rat. Ultrastructural and morphometric changes in parasympathetic nerves. Diabetes 1986 35 : 733 43.
68. Kniel PC, Junker U, Perrin IV et al. Varied effects of experimental diabetes on the autonomic nervous system of the rat. Lab Invest 1986 54 : 523 30.
69. Schmidt RE, Dorsey DA, Beaudet LN et al. Non-obese diabetic mice rapidly develop dramatic sympathetic neuritic dystrophy: a new experimental model of diabetic autonomic neuropathy. Am J Pathol 2003 163 : 2077 91.
70. Bour-Jordan H, Bluestone JA. Sensory neurons link the nervous system and autoimmune diabetes. Cell 2006 127 : 1097 9.
71. Wheway J, Mackay CR, Newton RA et al. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 2005 202 : 1527 38.
72. McGillis JP, Humphreys S, Reid S. Characterization of functional calcitonin gene-related peptide receptors on rat lymphocytes. J Immunol 1991 147 : 3482 9.
73. Gutierrez-Canas I, Juarranz Y, Santiago B et al. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) 2006 45 : 527 32.
74. Belai A, Lincoln J, Burnstock G. Lack of release of vasoactive intestinal polypeptide and calcitonin gene-related peptide during electrical stimulation of enteric nerves in streptozotocin-diabetic rats. Gastroenterology 1987 93 : 1034 40.
75. Belai A, Burnstock G. Changes in adrenergic and peptidergic nerves in the submucous plexus of streptozocin-diabetic rat ileum. Gastroenterology 1990 98 : 1427 36.
76. Schmidt RE, Plurad DA, Roth KA. Effects of chronic experimental streptozotocin-induced diabetes on the noradrenergic and peptidergic innervation of the rat alimentary tract. Brain Res 1988 458 : 353 60.